Log In
BCIQ
Print this Print this
 

Bionect, 0.2% hyaluronic acid

  Manage Alerts
Collapse Summary General Information
Company Cipher Pharmaceuticals Inc.
DescriptionLow moleuclar weight formulation of hyaluronic acid
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard IndicationDermatosis
Indication DetailsTreat skin irritation associated with radiation and chemotherapy
Regulatory Designation
PartnerMidatech Pharma plc;
Mission Pharmacal Co.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$27.4M

0

$5.8M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today